FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956358636> ?p ?o ?g. }

• W2956358636 endingPage "e548" @default.
• W2956358636 startingPage "e541" @default.
• W2956358636 abstract "Single-fraction (SF) radiation therapy is effective and convenient for patients with painful noncomplex bone metastases. Prior survey results reported a low recommendation of SF radiation therapy in the US. We sought to assess contemporary treatment recommendations for the management of bone metastases among diverse physicians participating in a statewide quality consortium.Members of the Michigan Radiation Oncology Quality Consortium were surveyed between April and May 2017. Physicians rated the importance of 31 variables on their choice of dose fractionation. The survey also covered 7 patient scenarios.Fifty-six physicians responded who were practicing at 18 of 20 centers surveyed. Respondents recommended 23 dose-fractionation schedules across the 7 scenarios. Highest-rated factors considered when choosing a dose fractionation regimen were performance status, prognosis, spinal cord compression, and prior radiation therapy. Recommendations for SF overall were uncommon (16.1%). On multivariable analysis, factors associated with SF use included academic employment (odds ratio [OR] 2.04; 95% CI, 1.02-4.08; P = .044) and higher palliative case volume (OR 2.59; 95% CI, 1.45-4.63; P = .001). Stereotactic body radiation therapy (SBRT) was recommended in 16.4% of scenarios overall, and on multivariable analysis, significant predictors for SBRT use were academic employment (OR 2.99; 95% CI, 1.39-6.44; P = .005), more recent residency completion (OR 4.37; 95% CI, 1.26-15.17; P = .02), spine location (OR 12.54; 95% CI, 3.96-39.68; P < .001), and prior radiation therapy (OR 26.67; 95% CI, 7.86-90.57; P < .001). SF rates were higher than in a survey reported in 2009 (16.1% vs 9.4%, P = .0004).SF radiation therapy remains uncommonly recommended, although it may be recommended more now than it was 10 years ago despite the increased utilization of SBRT. We identify multiple key drivers in physician decision making affecting SF recommendations that have not been addressed by prior level one evidence. Further research with evidence-based recommendations to clarify the role of SF and SBRT in management of patients with bony metastases are needed." @default.
• W2956358636 created "2019-07-23" @default.
• W2956358636 creator A5004113579 @default.
• W2956358636 creator A5012341053 @default.
• W2956358636 creator A5014527725 @default.
• W2956358636 creator A5036507987 @default.
• W2956358636 creator A5036540537 @default.
• W2956358636 creator A5053960294 @default.
• W2956358636 creator A5072230357 @default.
• W2956358636 creator A5076238068 @default.
• W2956358636 creator A5076973801 @default.
• W2956358636 creator A5082876219 @default.
• W2956358636 creator A5085774144 @default.
• W2956358636 creator A5087237904 @default.
• W2956358636 date "2019-11-01" @default.
• W2956358636 modified "2023-10-16" @default.
• W2956358636 title "Recommendations for Single-Fraction Radiation Therapy and Stereotactic Body Radiation Therapy in Palliative Treatment of Bone Metastases: A Statewide Practice Patterns Survey" @default.
• W2956358636 cites W1102190518 @default.
• W2956358636 cites W1589157904 @default.
• W2956358636 cites W1884379560 @default.
• W2956358636 cites W1969163240 @default.
• W2956358636 cites W1971021347 @default.
• W2956358636 cites W1980238474 @default.
• W2956358636 cites W2018038855 @default.
• W2956358636 cites W2025110241 @default.
• W2956358636 cites W2025442147 @default.
• W2956358636 cites W2068518767 @default.
• W2956358636 cites W2090681697 @default.
• W2956358636 cites W2094000412 @default.
• W2956358636 cites W2110069491 @default.
• W2956358636 cites W2143853878 @default.
• W2956358636 cites W2163957259 @default.
• W2956358636 cites W2166870452 @default.
• W2956358636 cites W2479968209 @default.
• W2956358636 cites W2536769127 @default.
• W2956358636 cites W2563557425 @default.
• W2956358636 cites W2775321189 @default.
• W2956358636 cites W2787804990 @default.
• W2956358636 cites W2790983120 @default.
• W2956358636 cites W2791844367 @default.
• W2956358636 cites W2898217460 @default.
• W2956358636 cites W2922307780 @default.
• W2956358636 cites W2939770857 @default.
• W2956358636 doi "https://doi.org/10.1016/j.prro.2019.07.005" @default.
• W2956358636 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31326530" @default.
• W2956358636 hasPublicationYear "2019" @default.
• W2956358636 type Work @default.
• W2956358636 sameAs 2956358636 @default.
• W2956358636 citedByCount "9" @default.
• W2956358636 countsByYear W29563586362019 @default.
• W2956358636 countsByYear W29563586362020 @default.
• W2956358636 countsByYear W29563586362021 @default.
• W2956358636 countsByYear W29563586362022 @default.
• W2956358636 countsByYear W29563586362023 @default.
• W2956358636 crossrefType "journal-article" @default.
• W2956358636 hasAuthorship W2956358636A5004113579 @default.
• W2956358636 hasAuthorship W2956358636A5012341053 @default.
• W2956358636 hasAuthorship W2956358636A5014527725 @default.
• W2956358636 hasAuthorship W2956358636A5036507987 @default.
• W2956358636 hasAuthorship W2956358636A5036540537 @default.
• W2956358636 hasAuthorship W2956358636A5053960294 @default.
• W2956358636 hasAuthorship W2956358636A5072230357 @default.
• W2956358636 hasAuthorship W2956358636A5076238068 @default.
• W2956358636 hasAuthorship W2956358636A5076973801 @default.
• W2956358636 hasAuthorship W2956358636A5082876219 @default.
• W2956358636 hasAuthorship W2956358636A5085774144 @default.
• W2956358636 hasAuthorship W2956358636A5087237904 @default.
• W2956358636 hasConcept C126322002 @default.
• W2956358636 hasConcept C155806632 @default.
• W2956358636 hasConcept C156957248 @default.
• W2956358636 hasConcept C159110408 @default.
• W2956358636 hasConcept C2778120868 @default.
• W2956358636 hasConcept C2779951463 @default.
• W2956358636 hasConcept C2780387249 @default.
• W2956358636 hasConcept C2781413609 @default.
• W2956358636 hasConcept C2992520072 @default.
• W2956358636 hasConcept C509974204 @default.
• W2956358636 hasConcept C71924100 @default.
• W2956358636 hasConceptScore W2956358636C126322002 @default.
• W2956358636 hasConceptScore W2956358636C155806632 @default.
• W2956358636 hasConceptScore W2956358636C156957248 @default.
• W2956358636 hasConceptScore W2956358636C159110408 @default.
• W2956358636 hasConceptScore W2956358636C2778120868 @default.
• W2956358636 hasConceptScore W2956358636C2779951463 @default.
• W2956358636 hasConceptScore W2956358636C2780387249 @default.
• W2956358636 hasConceptScore W2956358636C2781413609 @default.
• W2956358636 hasConceptScore W2956358636C2992520072 @default.
• W2956358636 hasConceptScore W2956358636C509974204 @default.
• W2956358636 hasConceptScore W2956358636C71924100 @default.
• W2956358636 hasIssue "6" @default.
• W2956358636 hasLocation W29563586361 @default.
• W2956358636 hasLocation W29563586362 @default.
• W2956358636 hasOpenAccess W2956358636 @default.
• W2956358636 hasPrimaryLocation W29563586361 @default.
• W2956358636 hasRelatedWork W1983863207 @default.
• W2956358636 hasRelatedWork W2007536764 @default.
• W2956358636 hasRelatedWork W2036120559 @default.
• W2956358636 hasRelatedWork W2039595483 @default.

• next